[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Cho Hyun-ui] The listing of Chinese companies on the U.S. stock market, which was halted in July last year due to regulations by Chinese authorities, will resume after seven months.


According to CNN on the 14th (local time), disposable medical equipment company Meihua International Medical Technology will debut on the U.S. Nasdaq this week. Meihua plans to raise $57.5 million (approximately 70 billion KRW) through this listing.


Excluding companies with headquarters in both China and the U.S., this is the first time since July last year that a company headquartered solely in China has listed in the U.S., following Shanghai-based financial services firm Centage Holdings.


Major foreign media reported that more than six Chinese companies have submitted listing documents to the New York Stock Exchange (NYSE) in recent weeks.


The initial public offerings (IPOs) planned by these companies are small-scale, within $35 million (approximately 4.2 billion KRW). Due to regulatory uncertainties, it is expected that large-scale IPOs will be unlikely for the time being.



Chinese companies raised $12.8 billion (approximately 15.4 trillion KRW) through U.S. stock listings from January to July last year, but regulations were significantly tightened after the ride-sharing company Didi Chuxing's listing on the New York Stock Exchange at the end of June.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing